Finance

Lists
Why is MCRB down 5,60%?
Dive Deeper
MCRB:NASDAQ
Seres Therapeutics Inc
2,53 USD
-5,60%
(-0,15) 1D
13-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MCRB...
Open
2,66 USD
High
2,66 USD
Low
2,51 USD
Mkt. cap
25,15 млн
Avg. vol.
71,56 миң
Volume
0,00
52-wk high
29,98 USD
52-wk low
2,42 USD
EPS
-2,33 USD
Beta
0,31
Shares outstanding
9,94 млн
No. of employees
66
Open
2,66 USD
High
2,66 USD
Low
2,51 USD
Mkt. cap
25,15 млн
Avg. vol.
71,56 миң
Volume
0,00
52-wk high
29,98 USD
52-wk low
2,42 USD
EPS
-2,33 USD
Beta
0,31
Shares outstanding
9,94 млн
No. of employees
66
News stories
From web sources and news partners
About Seres Therapeutics Inc
CEOEric Shaff
Employees66
Founded2010
Headquarters-
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to MCRB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MCRB in the last 3 months.
Highest
Current 2,53 USD
22,00 USD (+769,57%)
Average
17,00 USD (+571,94%)
Lowest
12,00 USD (+374,31%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
22,00 USD
+769,6%
08/06/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
12,00 USD
+374,3%
08/05/2026
Edward Tenthoff
Piper Sandler
Hold
Maintained
20,00 USD
+690,5%
02/13/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
11/05/2025
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
1,07 USD / -2,18 USD
+148,77%beat
Revenue / Est. (USD)
736,00 миң / 358,00 миң
+105,59%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
351,00 миң
438,00 миң
358,00 миң
736,00 миң
Cost of goods sold
13,35 млн
12,28 млн
13,20 млн
9,14 млн
Cost of revenue
13,35 млн
12,28 млн
13,20 млн
9,14 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,48 млн
7,54 млн
8,07 млн
7,06 млн
Operating expense
9,48 млн
7,54 млн
8,07 млн
7,06 млн
Total operating expenses
22,83 млн
19,82 млн
21,26 млн
16,20 млн
Operating income
-22,48 млн
-19,38 млн
-20,91 млн
-15,47 млн
Other non operating income
2,84 млн
2,33 млн
669,00 миң
673,00 миң
EBT including unusual items
8,20 млн
-15,34 млн
-19,91 млн
4,58 млн
EBT excluding unusual items
-19,02 млн
-16,60 млн
-19,91 млн
-14,61 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
8,20 млн
-15,34 млн
-19,91 млн
4,58 млн
Net profit margin
2 337,32%
-3 501,14%
-5 562,29%
622,42%
Earnings per share
0,94
-1,76
-2,08
1,07
Interest and investment income
618,00 миң
445,00 миң
325,00 миң
181,00 миң
Interest expense
-
-
-
-
Net interest expenses
618,00 миң
445,00 миң
325,00 миң
181,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,43 млн
-18,42 млн
-20,13 млн
-14,80 млн
Gain or loss from assets sale
-
-192,00 миң
-
139,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору